AURA Takes you to the home page
 

Aberdeen University Research Archive >
6 - All research >
All research >

Please use this identifier to cite or link to this item: http://hdl.handle.net/2164/2482

This item has been viewed 20 times in the last year. View Statistics

Files in This Item:

File Description SizeFormat
Hislop_2012.pdf213.41 kBAdobe PDFView/Open
Title: Systematic Review of Escalated Imatinib Doses Compared with Sunitinib or Best Supportive Care, for the Treatment of People with Unresectable/Metastatic Gastrointestinal Stromal Tumours Whose Disease has Progressed on the Standard Imatinib Dose
Authors: Hislop, Jennifer Margaret
Mowatt, Graham
Sharma, Pawana
Fraser, Cynthia Mary
Elders, Andrew Steven
Jenkinson, David James
Vale, Luke
Petty, Russell David
University of Aberdeen, School of Medicine & Dentistry, Division of Applied Health Sciences
University of Aberdeen, School of Medicine & Dentistry, Division of Applied Medicine
Keywords: GIST
gastrointestinal stromal tumours
unresectable
metastatic
cancer
imatinib
sunitinib
RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Issue Date: 2012
Citation: Hislop , J M , Mowatt , G , Sharma , P , Fraser , C M , Elders , A S , Jenkinson , D J , Vale , L & Petty , R D 2012 , ' Systematic Review of Escalated Imatinib Doses Compared with Sunitinib or Best Supportive Care, for the Treatment of People with Unresectable/Metastatic Gastrointestinal Stromal Tumours Whose Disease has Progressed on the Standard Imatinib Dose ' , Journal of Gastrointestinal CAncer , vol 43 , no. 2 , pp. 168-176 .
URI: http://hdl.handle.net/2164/2482
DOI: http://dx.doi.org/10.1007/s12029-011-9325-6
ISSN: 1941-6628
Rights: The original publication is available at www.springerlink.com. Open access was paid for by authors.
Appears in Collections:Applied Health Sciences research
Applied Medicine research
All research

SFX Query

Items in AURA are protected by copyright, with all rights reserved, unless otherwise indicated.

 


The University of Aberdeen
King's College
Aberdeen
AB24 3FX
Tel: +44 (0)1224-272000